Literature DB >> 5221361

Immunologic studies of thymectomized and nonthymectomized patients with myasthenia gravis.

M M Adner, C Isé, R Schwab, J D Sherman, W Dameshek.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1966        PMID: 5221361     DOI: 10.1111/j.1749-6632.1966.tb45501.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  8 in total

Review 1.  [The pathogenesis of myasthenia gravis as an immunological problem].

Authors:  J R Kalden
Journal:  Klin Wochenschr       Date:  1970-01-01

2.  Measurement of antibody-producing capacity in man. I. The normal response to flagellin from Salmonella adelaide.

Authors:  M J Rowley; I R Mackay
Journal:  Clin Exp Immunol       Date:  1969-10       Impact factor: 4.330

Review 3.  Phenotypic and functional analysis of lymphocytes in myasthenia gravis.

Authors:  A I Levinson; R P Lisak; B Zweiman; M Kornstein
Journal:  Springer Semin Immunopathol       Date:  1985

4.  Assessment of cellular and humoral immunity of myasthenics.

Authors:  S W Huang; J W Rose; R F Mayer
Journal:  J Neurol Neurosurg Psychiatry       Date:  1977-11       Impact factor: 10.154

5.  Clinical and immunological associations in myasthenia gravis. 2. Cell-mediated immunity.

Authors:  H J Sagar; G A Davies-Jones; I D Allonby
Journal:  J Neurol Neurosurg Psychiatry       Date:  1980-11       Impact factor: 10.154

6.  Lymphocyte function in myasthenia gravis.

Authors:  S Kawanami; A Kanaide; Y Itoyama; Y Kuroiwa
Journal:  J Neurol Neurosurg Psychiatry       Date:  1979-08       Impact factor: 10.154

7.  The immunological effects of thymectomy in myasthenia gravis.

Authors:  G K Scadding; H C Thomas; C W Havard
Journal:  Clin Exp Immunol       Date:  1979-05       Impact factor: 4.330

Review 8.  Experimental autoallergic myositis, polymyositis and myasthenia gravis. Autoimmune muscle disease associated with immunodeficiency and neoplasia.

Authors:  R L Dawkins
Journal:  Clin Exp Immunol       Date:  1975-08       Impact factor: 4.330

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.